Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 315 participants.
Also called NCT02954029
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 315 participants
- Registry
-
NCT02954029
-
- Other papers using this trial's data
- Hemostasis pad combined with compression device after transradial coronary procedures: A randomized controlled trial
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT02954029. Randomized; single masking; primary purpose treatment. Start 2016-04 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures
- Condition
- Coronary Artery Disease
- Condition
- Puncture
- Intervention (Device)
- ezClot (hemostasis pad)
- Intervention (Device)
- BloodSTOP ix pad
- Intervention (Device)
- Rotary compression device
- Lead sponsor
- Seoul National University Bundang Hospital
Record details
- Record id
cardio:ct-nct02954029- Content hash
65d60226e464a243d02df85b7ceb909b5e2278d8666381c91befe7a2963e1f65